Summary
Selegiline is a monoamine oxidase inhibitor used to treat major depressive disorder and Parkinson’s.

Brand Name
- Emsam
- Zelapar
Treatment Group
- Monoamine Oxidase (B) Inhibitors (MAOIs)
Medical Condition (Indication)
- Major Depressive Disorder (MDD)
- Parkinson’s Disease
Positive Drug Report Risk
- Amphetamine
- Methamphetamine
Resources
TBD
